View in EDS HTML Full Text PDF Full Text

EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression.

Saved in:
Bibliographic Details
Title: EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression.
Authors: Antin, C.1 (AUTHOR), Tauziède-Espariat, A.1 (AUTHOR) a.tauziede-espariat@ghu-paris.fr, Debily, M.-A.2,3 (AUTHOR), Castel, D.2,4 (AUTHOR), Grill, J.2,4 (AUTHOR), Pagès, M.1 (AUTHOR), Ayrault, O.5,6 (AUTHOR), Chrétien, F.1 (AUTHOR), Gareton, A.1 (AUTHOR), Andreiuolo, F.1 (AUTHOR), Lechapt, E.1 (AUTHOR), Varlet, P.1 (AUTHOR)
Source: Acta Neuropathologica Communications. 11/5/2020, Vol. 8 Issue 1, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20515960
DOI:10.1186/s40478-020-01056-8